Skip to main content
GDRX
NASDAQ Technology

GoodRx Flags Material Weaknesses in Financial Controls, Files 10-Q Late

Tom Rudovsky · Reported by Reuters
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$3.58
Mkt Cap
$1.245B
52W Low
$1.77
52W High
$3.89
52W Position info
102% above low
Off High info
8.0% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

GDRX has more than doubled off its 52-week low of $1.77.

Summary

GoodRx now expects to report one or more material weaknesses in its internal control over financial reporting, and it filed its Q3 10-Q with the SEC after the deadline. The company says it will release Q3 results and file the 10-Q within the five-calendar-day extension period. This lands nine days after the November 2 8-K disclosing that Q1 and Q2 2026 results must be restated after Pharma Direct revenue was understated by $29.8M over six months — the control failure is the root of that restatement, not a separate accounting surprise. For a company already showing an 89.4% net income decline and 4.4% revenue drop in Q1 2026, a late filing plus acknowledged control gaps raises the risk of further restatements and keeps the stock under pressure. Watch the Q3 release and 10-Q within the extension window for the size of any additional adjustments and whether management discloses remediation plans.

At the time of this announcement, GDRX was trading at $3.58 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $1.77 to $3.89. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

GDRX - Latest Insights

GDRX
Nov 02, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.55
Real-time Price: $3.58 info
Change: +$0.030 (+0.85%) info
Market Cap: $1.245B info
GDRX
Aug 26, 2026, 9:24 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $3.48
Real-time Price: $3.58 info
Change: +$0.100 (+3%) info
Market Cap: $1.245B info
GDRX
Aug 26, 2026, 9:20 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $3.48
Real-time Price: $3.58 info
Change: +$0.100 (+3%) info
Market Cap: $1.245B info
GDRX
Aug 05, 2026, 5:09 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $3.43
Real-time Price: $3.58 info
Change: +$0.150 (+4%) info
Market Cap: $1.245B info
GDRX
May 06, 2026, 4:31 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.57
Real-time Price: $3.58 info
Change: +$1.01 (+39%) info
Market Cap: $1.245B info